LCT 0.01
Final Director's Interest Notice - Bernie Tuch
Final Director's Interest Notice for Professor Bernie Tuch.
Final Director's Interest Notice - A Kelly
Final Director's Interest Notice for Dr Andrew Kelly.
Quarterly Activity Report and Appendix 4C
Living Cell Technologies announced today its Activity and Cashflow (Appendix 4C) Report for the quarter ended 30 September 2022, highlighted by the successful shipment of choroid plexus tissue to Sydney as the Company advances its third clinical trial of NTCELL in Parkinson’s disease.
Online attendance option for 2022 Annual General Meeting
Living Cell Technologies advises shareholders can now attend the Company’s upcoming Annual General Meeting (AGM) either in person or online. The AGM will be held from 2pm AEDT on Thursday, 10 November 2022.
Chairman's Letter to Shareholders
Living Cell Technologies provides an update by Executive Chairman, Professor Bernie Tuch, regarding the 2022 Annual General Meeting of shareholders, to be held from 2pm AEDT on Thursday, 10 November 2022.